Post renal transplantation Kaposi's sarcoma: A review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy

Transplant Infectious Disease

Volumn 14, Issue 4, 2012, Pages 338-345

  Hosseini Moghaddam, S M ^a,b   Soleimanirahbar, A ^b   Mazzulli, T ^c   Rotstein, C ^a   Husain, S ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Human herpesvirus 8; Kaposi's sarcoma; Kidney transplantation

Indexed keywords

BLEOMYCIN; DOCETAXEL; INTERLEUKIN 2 RECEPTOR ANTIBODY; PACLITAXEL; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS ASSOCIATED KAPOSI SARCOMA; BIRTHPLACE; CANCER PROGNOSIS; GENETIC ASSOCIATION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LATENT PERIOD; MEDLINE; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROLOGY; SEROPREVALENCE; SKIN COLOR; SOLID ORGAN TRANSPLANTATION; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EUROPE; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MIDDLE EAST; SARCOMA, KAPOSI;

EID: 84865175767     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00714.x     Document Type: Review

References (38)

1. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65(2): 253-261.
2. Hu J, McKoy K, Papier A, et al. Dermatology and HIV/AIDS in Africa. J Glob Infect Dis 2011; 3(3): 275-280.
3. Dudderidge TJ, Khalifa M, Jeffery R, Amlot P, Al-Akraa M, Sweny P. Donor-derived human herpes virus 8-related Kaposi's sarcoma in renal allograft ureter. Transpl Infect Dis 2008; 10(3): 221-226.
4. Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 2000; 88(3): 500-517.
5. Pellet C, Kerob D, Dupuy A, et al. Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma. J Invest Dermatol 2006; 126(3): 621-627.
6. Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation 2011; 92(8): 837-844.
7. Zmonarski SC, Boratynska M, Puziewicz-Zmonarska A, Kazimierczak K, Klinger M. Kaposi's sarcoma in renal transplant recipients. Ann Transplant 2005; 10(2): 59-65.
8. Diociaiuti A, Nanni G, Cattani P, et al. HHV8 in renal transplant recipients. Transpl Int 2000; 13(Suppl 1): S410-412.
9. Bergallo M, Costa C, Margio S, et al. Human herpes virus 8 infection in kidney transplant patients from an area of northwestern Italy (Piemonte region). Nephrol Dial Transplant 2007; 22(6): 1757-1761.
10. Huang JY, Chiang YJ, Lai PC, et al. Posttransplant Kaposi's sarcoma: report from a single center. Transplant Proc 2004; 36(7): 2145-2147.
11. Al-Otaibi LM, Ngui SL, Scully CM, Porter SR, Teo CG. Salivary human herpesvirus 8 shedding in renal allograft recipients with Kaposi's sarcoma. J Med Virol 2007; 79(9): 1357-1365.
12. Kolhe N, Mamode N, Van Der Walt J, Pattison J. Regression of post-transplant Kaposi's sarcoma using sirolimus. Int J Clin Pract 2006; 60(11): 1509-1512.
13. Gonzalez-Lopez MA, Rodrigo E, Gonzalez-Vela MC, Fernandez-Llaca H, Arias-Rodriguez MA, Val-Bernal JF. Posttransplant Kaposi's sarcoma restricted to the site of a previous deep venous thrombosis: abrupt onset after withdrawal of sirolimus. Dermatology 2006; 213(1): 30-33.
14. Gazouli M, Zavos G, Papaconstantinou I, et al. The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients. Anticancer Res 2004; 24(2C): 1311-1314.
15. Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 2010; 120 (4): 939-949.
16. Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 2000; 96(9): 3279-3281.
17. Luppi M, Barozzi P, Guaraldi G, et al. Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor. Clin Infect Dis 2003; 37 (4): 606-607; author reply 607.
18. Barozzi P, Bosco R, Vallerini D, et al. KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney. Transplantation 2006; 82(6): 851-852.
19. Frances C, Marcelin AG, Legendre C, et al. The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival. Am J Transplant 2009; 9(11): 2580-2586.
20. Alzahrani AJ, El-Harith El HA, Milzer J, et al. Increased seroprevalence of human herpes virus-8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant 2005; 20(11): 2532-2536.
21. Stein L, Carrara H, Norman R, Alagiozoglou L, Morris L, Sitas F. Antibodies against human herpesvirus 8 in South African renal transplant recipients and blood donors. Transpl Infect Dis 2004; 6(2): 69-73.
22. Al-Otaibi LM, Al-Sulaiman MH, Teo CG, Porter SR. Extensive oral shedding of human herpesvirus 8 in a renal allograft recipient. Oral Microbiol Immunol 2009; 24(2): 109-115.
23. Laney AS, Peters JS, Manzi SM, Kingsley LA, Chang Y, Moore PS. Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection. J Clin Microbiol 2006; 44(10): 3734-3741.
24. Razonable RR, Zerr DM. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4): S97-100.
25. Babel N, Eibl N, Ulrich C, et al. Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod. Transpl Infect Dis 2008; 10(1): 59-62.
26. Pellet C, Chevret S, Frances C, et al. Prognostic value of quantitative Kaposi sarcoma-associated herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis 2002; 186(1): 110-113.
27. Hayward GS, Zong JC. Modern evolutionary history of the human KSHV genome. Curr Top Microbiol Immunol 2007; 312: 1-42.
28. Weigert AL, Pires A, Adragao T, et al. Human herpes virus-8 serology and DNA analysis in recipients of renal allografts showing Kaposi's sarcoma and their respective donors. Transplant Proc 2004; 36(4): 902-904.
29. Barete S, Calvez V, Mouquet C, et al. Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients. Arch Dermatol 2000; 136(12): 1452-1458.
30. Boulanger E, Afonso PV, Yahiaoui Y, Adle-Biassette H, Gabarre J, Agbalika F. Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin. Am J Transplant 2008; 8(3): 707-710.
31. Bossini N, Sandrini S, Setti G, et al. [Successful treatment with liposomal doxorubicin and foscarnet in a patient with widespread Kaposi's sarcoma and human herpes virus 8-related, serious hemophagocytic syndrome, after renal transplantation]. G Ital Nefrol 2005; 22(3): 281-286.
32. Luppi M, Barozzi P, Schulz TF, et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 2000; 343(19): 1378-1385.
33. Sakagami J, Sogame Y, Kataoka K, et al. Endoscopic resection for the diagnosis of visceral Kaposi's sarcoma. J Gastroenterol 2005; 40(1): 98-103.
34. Frances C. Kaposi's sarcoma after renal transplantation. Nephrol Dial Transplant 1998; 13(11): 2768-2773.
35. Segoloni GP, Giraudi R, Messina M, et al. No recurrence of Kaposi's sarcoma in a case of renal retransplantation under a calcineurin inhibitor free immunosuppressive regimen: first report. Transpl Int 2007; 20(4): 395-396.
36. Patel N, Salifu M, Sumrani N, et al. Successful treatment of post-renal transplant Kaposi's sarcoma with paclitaxel. Am J Transplant 2002; 2(9): 877-879.
37. Luppi M, Barozzi P, Rasini V, et al. Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation 2002; 74(1): 131-132.
38. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342(14): 1027-1038.